급성 뇌경색 환자에서 Atorvastatin 20 mg 투여 후 high sensitive C-reactive protein의 변화

참고문헌 (23)

1. "Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis", 177, pp.433~442 (2004)
2. "Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis", 35, pp.2902~2909 (2004)
3. "Atherosclerotic disease regression with statins: studies using vascular markers", 96, pp.447~459 (2004)
4. "Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology", 15, pp.637~643 (2004)
5. "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial", 110, pp.1406~1412 (2004)
6. "The pleiotropic effects of statins", 20, pp.541~546 (2005)
7. "Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members", 36, pp.1316~1329 (2005)
8. "Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial", 46, pp.1417~1424 (2005)
9. "Expanding indications for statins in cerebral ischemia: a quantitative study", 62, pp.67~72 (2005)
10. "Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial", 28, pp.307~310 (1997)
11. "Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project", 105, pp.2341~2346 (2002)
12. "Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial", 96, pp.61~68 (2005)
13. "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report", 106, pp.3143~3421 (2002)
14. "Effects of cholesterol- lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions", 363, pp.757~767 (2004)
15. "Vienna Stroke Study Group. Determination of lipid profiles and use ofstatins in patients with ischemic stroke or transient ischemic attack", 34, pp.105~110
16. "Role of inflammation in stroke and atherothrombosis", 17, pp.1~5 (2004)
17. "C-reactive protein in ischemic stroke: an independent prognostic factor", 32, pp.917~924 (2001)
18. "Inflammation, statins, and outcome after ischemic stroke", 32, pp.2446~2447 (2001)
19. "Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study", 149, pp.451~457 (2005)
20. "American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association", 107, pp.499~511 (2003)
21. "The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen", 106, pp.291~297 (2006)
22. "Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to Chlamydia pneumoniae", 84, pp.595~598 (1999)
23. "Change in circulating C-reactive protein is not associated with atorvastatin treatment in Alzheimer's disease", 28, pp.621~624 (2006)

관련 논문AI추천